Medicxi Ventures Management
Latest statistics and disclosures from Medicxi Ventures Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CNTA, PHAT, NAMS, Rapt Therapeutics, AURA, and represent 100.00% of Medicxi Ventures Management's stock portfolio.
- Medicxi Ventures Management has $835M in assets under management (AUM), dropping by 12.17%.
- Central Index Key (CIK): 0001715579
Tip: Access up to 7 years of quarterly data
Positions held by Medicxi Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Medicxi Ventures Management
Medicxi Ventures Management holds 5 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 59.8 | $499M | 20M | 25.01 |
|
|
| Phathom Pharmaceuticals (PHAT) | 14.8 | $124M | 7.5M | 16.59 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 12.1 | $101M | 2.9M | 35.08 |
|
|
| Rapt Therapeutics | 11.3 | $95M | 2.8M | 33.87 |
|
|
| Aura Biosciences (AURA) | 2.0 | $17M | 3.0M | 5.45 |
|
Past Filings by Medicxi Ventures Management
SEC 13F filings are viewable for Medicxi Ventures Management going back to 2019
- Medicxi Ventures Management 2025 Q4 filed Jan. 23, 2026
- Medicxi Ventures Management 2025 Q3 filed Oct. 17, 2025
- Medicxi Ventures Management 2025 Q2 filed July 8, 2025
- Medicxi Ventures Management 2025 Q1 filed April 11, 2025
- Medicxi Ventures Management 2024 Q4 filed Jan. 23, 2025
- Medicxi Ventures Management 2024 Q3 filed Oct. 15, 2024
- Medicxi Ventures Management 2024 Q2 filed July 16, 2024
- Medicxi Ventures Management 2024 Q1 filed April 15, 2024
- Medicxi Ventures Management 2023 Q4 filed Feb. 1, 2024
- Medicxi Ventures Management 2023 Q3 filed Oct. 18, 2023
- Medicxi Ventures Management 2023 Q2 filed July 19, 2023
- Medicxi Ventures Management 2023 Q1 filed April 27, 2023
- Medicxi Ventures Management 2022 Q4 filed Jan. 31, 2023
- Medicxi Ventures Management 2022 Q3 filed Oct. 25, 2022
- Medicxi Ventures Management 2022 Q2 filed Aug. 3, 2022
- Medicxi Ventures Management 2022 Q2 restated filed Aug. 3, 2022